Search Results - Juchuanli Tu
- Showing 1 - 4 results of 4
-
1
-
2
Discovery of a first-in-class ANXA3 degrader for the treatment of triple-negative breast cancer by Yongxi Liang, Delin Min, Hulin Fan, Kunlin Liu, Juchuanli Tu, Xueyan He, Bingjie Liu, Lu Zhou, Suling Liu, Xun Sun
Published in Acta Pharmaceutica Sinica B (2023-04-01)Get full text
Article -
3
Ccl3 enhances docetaxel chemosensitivity in breast cancer by triggering proinflammatory macrophage polarization by Tong Liu, Rui Zhang, Wei Ma, Dong Wang, Lei Zhou, Yin Liu, Dandan Sheng, Qiaodan Deng, Juchuanli Tu, Weilong Chen, Fuchuang Zhang, Nailong Gao, Mengxue Dong, Fengkai Li, Xueyan He, Shengzhong Duan, Lixing Zhang, Suling Liu
Published in Journal for ImmunoTherapy of Cancer (2022-05-01)Get full text
Article -
4
SOSTDC1 Nuclear Translocation Facilitates BTIC Maintenance and CHD1‐Mediated HR Repair to Promote Tumor Progression and Olaparib Resistance in TNBC by Qiaodan Deng, Jiankun Qiang, Cuicui Liu, Jiajun Ding, Juchuanli Tu, Xueyan He, Jie Xia, Xilei Peng, Siqin Li, Xian Chen, Wei Ma, Lu Zhang, Yi‐Zhou Jiang, Zhi‐Ming Shao, Ceshi Chen, Suling Liu, Jiahui Xu, Lixing Zhang
Published in Advanced Science (2024-08-01)Get full text
Article
